Get notified when DNTH files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NASDAQ: DNTH Dianthus Therapeutics, Inc. /DE/ 8-K

Dianthus Therapeutics reports Q1 2026 financial results

Filed May 5, 2026 · Period ending May 5, 2026 · ~1 min read

Key Changes

  • medium

    Company issued press release announcing financial results for the quarter ended March 31, 2026. Actual figures not included in the 8-K filing itself.

    Item 2.02 verify on EDGAR →
  • medium

    Full financial details are contained in attached press release (Exhibit 99.1), which is referenced but not summarized in the filing body.

    Exhibit 99.1 view on EDGAR →

This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (FNGR 10-Q) is open in full — no account needed.

Partner

Trade DNTH commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?
View original filing on SEC.gov Press release (Ex 99.1) on EDGAR ↗

Source-verified from EDGAR · Narrative written by AI · Jun 2, 2026 · How we verify